(Q87542159)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Kazumichi Kawakubo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

23

Kazuhiko Koike

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Naminatsu Takahara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hiroyuki Isayama

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Yousuke Nakai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Takashi Sasaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hironori Ishigami

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hironori Yamaguchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Tsuyoshi Hamada

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Rie Uchino

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Suguru Mizuno

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Koji Miyabayashi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Dai Mohri

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hirofumi Kogure

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Natsuyo Yamamoto

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Naoki Sasahira

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Kenji Hirano

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hideaki Ijichi

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Keisuke Tateishi

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Minoru Tada

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Joji Kitayama

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Toshiaki Watanabe

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

1 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

Journal of gastrointestinal cancer

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

307-311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan

12 March 2020

cites work

1 reference

12 December 2020

Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas

1 reference

12 December 2020

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.

1 reference

12 December 2020

Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study

1 reference

12 December 2020

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

1 reference

12 December 2020

Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study

1 reference

12 December 2020

Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer.

1 reference

12 December 2020

Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group).

1 reference

12 December 2020

Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma

1 reference

12 December 2020

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

12 December 2020

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

1 reference

12 December 2020

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

12 December 2020

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group

1 reference

12 December 2020

Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients

1 reference

12 December 2020

Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA

1 reference

12 December 2020

Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer

1 reference

12 December 2020

Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma.

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

10.1007/S12029-014-9603-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676891%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference